Does the pattern of amphetamine use prior to incarceration predict later psychosis?-A longitudinal study of amphetamine users in the Swedish criminal justice system

Drug and Alcohol Dependence

Volumn 143, Issue 1, 2014, Pages 219-224

  Rognli, Eline Borger ^a,d   Håkansson, Anders ^b,d   Berge, Jonas ^b,d   Bramness, Jørgen G ^a,c,d  

^a UNIVERSITY OF OSLO   (Norway)

^b LUND UNIVERSITY   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d NONE   (Norway)

Author keywords

Amphetamine; Methamphetamine; Prison; Psychosis; Schizophrenia

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; BEHAVIOR DISORDER ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CRIMINAL JUSTICE; DRUG USE; EUROPEAN VERSION OF THE ADDICTION SEVERITY INDEX; FEMALE; FOLLOW UP; HALLUCINATION; HOMELESSNESS; HOSPITALIZATION; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PSYCHOSIS; RISK FACTOR; SCANDINAVIA; SELF REPORT; SWEDEN; ADOLESCENT; DRUG ABUSE; MIDDLE AGED; PRISONER; PSYCHOLOGY; PSYCHOSES, SUBSTANCE-INDUCED; RISK; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRISONERS; PSYCHOSES, SUBSTANCE-INDUCED; RISK; SWEDEN;

EID: 84922402465     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.07.037     Document Type: Article

References (49)

1. Akiyama K. Longitudinal clinical course following pharmacological treatment of metamphetamie psychosis which persists after long-term abstinence. Ann. N.Y. Acad. Sci. 2006, 1074:125-134.
2. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biol. Psychiatry 1970, 2:95-107.
3. Angrist B.M., Sathananthan G., Wilk S., Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J. Psychiatr. Res. 1974, 11:13-23.
4. Barr A.M., Panenka W.J., MacEwan G.W., Thornton A.E., Lang D.J., Honer W.G., Lecomte T. The need for speed: an update on methamphetamine addiction. J. Psychiatry Neurosci. 2006, 31:301.
5. Batki S.L., Harris D.S. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am. J. Addict. 2010, 13:461-470.
6. Bell D.S. The experimental reproduction of amphetamine psychosis. Arch. Gen. Psychiatry 1973, 29:35-40.
7. Bousman C.A., Glatt S.J., Everall I.P., Tsuang M.T. Methamphetamine-associated psychosis: a model for biomarker discovery in schizophrenia. Handbook of Schizophrenia Spectrum Disorders, Volume I 2011, 327-343. Springer, New York, NY. M.S. Ritsner (Ed.).
8. Brady K.T., Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am. J. Psychiatry 2005, 162:1483-1493.
9. Bramness J.G., Gundersen Ø.H., Guterstam J., Rognli E.B., Konstenius M., Løberg E.-M., Medhus S., Tanum L., Franck J. Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable?. BMC Psychiatry 2012, 12:221.
10. Bühler B., Hambrecht M., Löffler W., Häfner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res. 2002, 54:243-251.
11. Callaghan R.C., Cunningham J.K., Allebeck P., Arenovich T., Sajeev G., Remington G., Boileau I., Kish S.J. Methamphetamine use and schizophrenia: a population-based cohort study in California. Am. J. Psychiatry 2012, 169:389-396.
12. Caton C.L.M., Hasin D., Shrout P.E., Drake R.E., Dominguez B., First M.B., Samet S., Schanzer W.B. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br. J. Psychiatry 2007, 190:105-111.
13. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E., Murray R.M. Morbid risk for psychiatric disorder among the relatives of metamphetamine users with and without psychosis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 136B:87-91.
14. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., Hsiao C.C., Chiang Y.L., Ree S.C., Lee C.H., Murray R.M. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol. Med. 2003, 33:1407-1414.
15. Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., Malaspina D. The stress cascade and schizophrenia: etiology and onset. Schizophr. Bull. 2003, 29:671-692.
16. Curran C., Byrappa N., Mcbride A. Stimulant psychosis: systematic review. Br. J. Psychiatry 2004, 185:196-204.
17. Durbeej N., Berman A.H., Gumpert C.H., Palmstierna T., Kristiansson M., Alm C. Validation of the alcohol use disorders identification test and the drug use disorders identification test in a Swedish sample of suspected offenders with signs of mental health problems: results from the mental disorder, substance abuse and crime study. J. Subst. Abuse Treat. 2010, 39:364-377.
18. European Monitoring Centre for Drugs and Drug Addiction The State of Drugs Problem In Europe. Annual Report 2002 2002, European Monitoring Centre For Drugs and Drug Addiction (EMCDDA), Luxembourg.
19. European Monitoring Centre for Drugs and Drug Addiction The State of The Drugs Problem In Europe. Annual Report 2012 2012, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Luxembourg.
20. Fazel S., Danesh J. Serious mental disorder in 23,000 prisoners: a systematic review of 62 surveys. Lancet 2002, 359:545-550.
21. Fazel S., Khosla V., Doll H., Geddes J. The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Med. 2008, 5:e225.
22. Folsom D., Jeste D. Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr. Scand. 2002, 105:404-413.
23. Grant K.M., LeVan T.D., Wells S.M., Li M., Stoltenberg S.F., Gendelman H.E., Carlo G., Bevins R.A. Methamphetamine-associated psychosis. J. Neuroimmune Pharmacol. 2011, 7:113-139.
24. Griffiths J., Oates J., Cavanaugh J. Paranoid episodes induced by drugs. JAMA 1968, 205:39-46.
25. Hakansson A., Schlyter F., Berglund M. Characteristics of primary amphetamine users in Sweden: a criminal justice population examined with the addiction severity index. Eur. Addict. Res. 2008, 15:10-18.
26. Helseth V., Lykke-Enger T., Johnsen J., Waal H. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord. J. Psychiatry 2009, 63:72-77.
27. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.-U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8.
28. Kittirattanapaiboon P., Mahatnirunkul S., Booncharoen H., Thummawomg P., Dumrongchai U., Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010, 29:456-461.
29. Kokkevi A., Hartgers C. EuropASI. European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur. Addict. Res. 1995, 1:208-210.
30. Lechner W.V., Dahne J., Chen K.W., Pickover A., Richards J.M., Daughters S.B., Lejuez C. The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms. Drug Alcohol Depend. 2013, 131:78-84.
31. Lecomte T., Mueser K.T., MacEwan W., Thornton A.E., Buchanan T., Bouchard V., Goldner E., Brink J., Lang D., Kang S. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J. Nerv. Ment. Dis. 2013, 201:1085-1089.
32. Lichlyter B., Purdon S., Tibbo P. Predictors of psychosis severity in individuals with primary stimulant addictions. Addict. Behav. 2011, 36:137-139.
33. Lim C., Chong S.-A., Keefe R.S. Psychosocial factors in the neurobiology of schizophrenia: a selective review. Ann. Acad. Med. Singapore 2009, 38:402-406.
34. Marshall B.D., Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010, 105:991-1002.
35. McKetin R., Hickey K., Devlin K., Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alochol Rev. 2010, 29:358-363.
36. McKetin R., Lubman D.I., Baker A.L., Dawe S., Ali R.L. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry 2013, 70:319-324.
37. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006, 101:1473-1478.
38. McLellan A.T., Luborsky L., Woody G., O'brien C. An improved diagnostic evaluation instrument for substance abuse patients. J. Nerv. Ment. Dis. 1980, 168:26-33.
39. Medhus S., Mordal J., Holm B., Mørland J., Bramness J.G. A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Res. 2012, 206:17-21.
40. Nuevo R., Chatterji S., Verdes E., Naidoo N., Arango C., Ayuso-Mateos J.L. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr. Bull. 2012, 38:475-485.
41. Öberg D., Zingmark D., Sallmén B. ASI-X v 2.02 2002, http://www.emcdda.europa.eu/attachements.cfm/att_23587_EN_EuropAsi%20Interview%20form%20EN.pdf (accessed 01.01.02).
42. Panenka W.J., Procyshyn R.M., Lecomte T., MacEwan G.W., Flynn S.W., Honer W.G., Barr A.M. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend. 2013, 129:167-179.
43. Robinson D., Woerner M.G., Alvir J.M.J., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999, 56:241-247.
44. Salo R., Nordahl T.E., Leamon M.H., Natsuaki Y., Moore C.D., Waters C., Carter C.S. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res. 2008, 157:273-277.
45. Svennerlind C., Nilsson T., Kerekes N., Andiné P., Lagerkvist M., Forsman A., Anckarsäter H., Malmgren H. Mentally disordered criminal offenders in the Swedish criminal system. Int. J. Law Psychiatry 2010, 33:220-226.
46. Ujike H., Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N.Y. Acad. Sci. 2006, 1025:279-287.
47. Van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39:179.
48. Verdoux H., van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 2002, 54:59-65.
49. Zorick T.S., Rad D., Rim C., Tsuang J. An overview of methamphetamine-induced psychotic syndromes. Addict. Disord. Treat. 2008, 7:143-156.